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INTRODUCTION 
 
                 There has always been a big question if it was possible to do 
tracheal intubation without muscle relaxants. Tracheal intubation with deep 
inhalational induction is done in children and in special conditions where 
neuromuscular blockers cannot be used like hyperkalemia, plasma 
cholinesterase deficiency, increased intracranial pressure, malignant 
hyperthermia, penetrating eye injury, burns, recent spinal cord injury and 
known allergic reactions.  
 
                                  Though some of these adverse effects caused by 
succinylcholine could be avoided with the use of non - depolarizing muscle 
relaxants, still non depolarizing muscle relaxants could also be associated 
with adverse effects like prolonged paralysis or when there is an 
impossibility of reversing the neuromuscular blockade during CVCI (can’t 
ventilate can’t intubate) where the airway couldn’t be managed with mask 
ventilation or tracheal intubation.   
                 
                                   Some neuromuscular disorders for example 
myasthenia gravis alter the clinical pharmacology of muscle relaxants and 
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can cause alterations in the dosage, choice, and reversal of the muscle 
relaxant. Hence in these scenarios, tracheal intubation free of neuromuscular 
blocking agents is frequently done.
1
  
               
                                  This technique is also useful where neuromuscular 
blockade is not needed to facilitate surgical access like ambulatory 
surgery.
2,3
 Neurosurgical procedures which needs evoked potential 
monitoring and some surgical procedures such as facial nerve exploration 
and few thyroid surgeries which may necessitate the use of nerve stimulator 
for identification of nerves and confirmation of their integrity, a 
neuromuscular block free based intubation is required.  
                 
                              Various techniques of induction can be used to achieve 
tracheal intubation free of neuromuscular blockade. Intravenous or 
inhalational induction can be used. A bolus dose propofol without 
concomitant opioid has been used in the past for tracheal intubation but 
because of inferior intubating conditions, it was used with concomitant 
fentanyl which lead to better intubating conditions.
4
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                                 Upper airway reflexes were more depressed with 
propofol compared with thiopentone while performing laryngoscopy when 
given in an equipotent dose which is the reason for its use for facilitating 
laryngeal mask airway placement. Propofol was found to have better 
intubating conditions compared to thiopentone when combined with 
remifentanil.
5,6
  
                     
                               High concentrations of sevoflurane is usually used in 
children for intubation without neuromuscular blockade.
7
 Sevoflurane has 
been studied to be a preferred agent in adults for anesthetic induction and it 
can be used alone or with nitrous oxide.
8
 Both sevoflurane and propofol 
induction has been used in management of difficult airway.
9
 But sevoflurane 
has its advantage in the maintenance of spontaneous ventilation. Sevoflurane 
mask induction has been studied with adjuvants like midazolam or fentanyl 
and has been shown in the reduction of time to obtain optimal intubating 
conditions in adults.
10 
 
                   
                            The aim of our study was to determine if sevoflurane – 
fentanyl combination would offer equivalent intubating conditions when 
compared with propofol – fentanyl combination. 
 4 
 
AIM 
 
Aim of the study was to compare the effectiveness of sevoflurane and 
propofol with fentanyl for tracheal intubation without muscle Relaxant. 
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VIEW OF LARYNX AT LARYNGOSCOPY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
 
PHARMACOLOGY 
 
SEVOFLURANE: 
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Sevoflurane is a halogenated fluoride. Sevoflurane has blood gas solubility 
of 0.69 and MAC value of 2% and together with its non-pungent odour and 
rapid increase in alveolar concentration makes it a better choice for smooth 
and rapid induction of agent in both pediatric and adult patients. An 
advantage is its rapid emergence because of its low blood gas solubility. 
Inhalational induction can be done with 8% sevoflurane in a 50% mixture of 
nitrous oxide and oxygen and tracheal intubation could be obtained in 1–3 
minutes. Delirium associated with sevoflurane can be treated with 1-2 µg/kg 
fentanyl. 
 
Cardiovascular effects 
 Sevoflurane causes mild depression of myocardial contractility.  
 Systemic vascular resistance and blood pressure falls slightly less than 
with isoflurane or desflurane.  
 In contrast to isoflurane and desflurane, sevoflurane doesn’t alter heart 
rate or cause cardiovascular stimulation during rapid increases in 
anesthetic concentration in humans.  
 It maintains cardiac output because sevoflurane produce less reduction 
in myocardial contractility and greater decreases in systemic vascular 
resistance 
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Respiratory effects 
                           It depresses respiration and hypoxic ventilatory drive. It 
also reverses bronchospasm becauses of its bronchodilator property although 
less than halothane.  
 
CNS effects 
                           Sevoflurane causes slight increase in cerebral blood flow 
and intracranial preesure. Autoregulation of cerebral blood flow may be 
impaired when used in concentration of > 1.5 MAC.  
 
Neuromuscular action 
                          Sevoflurane produces adequate muscle relaxation for 
intubation following an inhalation induction. 
 
Renal effects 
 Sevoflurane slightly decreases renal blood flow.  
 High fluoride levels and compound A can be associated with impaired 
renal tubule function.   
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(Buthionine-(S,R)-sulfoximine (BSO), acivicin (AT-125), and 
aminooxyacetic acid (AOAA) inhibits the activity of β-lyase ) 
 
 Sevoflurane has less nephrotoxic potential which was indicated by 
urine-concentrating ability and the production of N-acetyl-β-
glucosaminidase (NAG), an indicator of renal tubular damage.  
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 Compound A is formed by the interaction of sevoflurane and soda 
lime under low flow anesthesia. 
 
Hepatic effects 
                               Though it decreases portal vein blood flow, it also 
increases hepatic artery blood flow, thus maintaining the total hepatic blood 
flow and oxygen delivery. 
 
Metabolism  
                              Sevoflurane is metabolized by liver microsomal enzyme 
P-450-2E1. There is no association with peak fluoride levels following 
sevoflurane administration and  renal concentrating abnormality.  
 
Compound A 
                            Fluoromethyl-2-2-difluoro-1-(trifluoromethyl) vinyl ether 
(compound A) is the major degradation product of sevoflurane. The 
dehydrofluorination of sevoflurane to form compound A is initiated by soda 
lime abstraction of a proton from the isopropyl group of sevoflurane.  
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                                 In a rebreathing system with a carbon dioxide absorber 
in lime (soda lime or Baralyme), patients exposed to sevoflurane will 
breathe compound A. The typical levels seen in clinical conditions will vary 
and are dependent on several factors, the most important being the inspired 
fresh gas flow rate.  
 
                                The key factor in determining potential toxicity from 
sevoflurane is total exposure rather than the absolute concentration, with 
exposure being expressed as the product of concentration and time.  
 
                              At a fresh gas inflow of 2 L/min, these levels would be 
expected to be seen only in conditions of prolonged sevoflurane exposure 
and are not of concern to the vast majority of patients undergoing anesthesia 
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Inhalational induction 
 
There are 3 types of inhalational induction: 
 
 VIMA(volatile induction and maintenance of anesthesia) 
 Overpressure induction(vital capacity breath induction) 
 Incremental induction 
 
                              Many techniques can be followed for inhalational 
induction for tracheal intubation.  
 
1. First method is induction with sevoflurane 8% and N2O 66%;  
 
2. Second method is induction with oxygen 100% and sevoflurane 8%.  
 
3. Studies indicate that the average time for  sevoflurane and oxygen 
100% combination was 6.4 min, and sevoflurane and nitrous oxide 
66% combination was 4.7 min.  
 
 13 
 
4. Hence it is found that a longer period is needed in adults even when 
induction is done with sevoflurane 8%. 
 
                            Inhalation of volatile agents was an age old technique of 
administering anesthesia. It is useful in situations where is a lack of venous 
access and anticipated airway difficulty.  
 
                          A major advantage of inhalational induction of anesthesia is 
the maintenance of spontaneous ventilation although there could be 
associated respiratory and cardiovascular effects which occur gradually as 
the depth of anesthesia is increased. It needs good facemask ventilation to 
prevent leaks around the mask and to prevent airway obstruction. 
 
                             Deep anesthesia is needed for laryngoscopy and tracheal 
intubation with volatile agents alone. Sevoflurane has muscle relaxant 
property which allows the insertion of laryngeal mask airway (LMA) or 
endotracheal tube. A depth of anesthesia that allows controlled ventilation 
has been recommended when sevoflurane is used.  
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                            Increased depth of anesthesia can cause complications like 
hypoventilation, obstruction, hypotension and bradycardia due to 
cardiovascular depression. Prior administration of topical anesthesia with 
4% lidocaine can facilitate tracheal intubation under inhaled anesthesia. 
Clinical end points for tracheal intubation are loss of lid lash reflex and  
convergence of pupils to midline. 
                            
                              Sevoflurane has advantages over other volatile anesthetics 
for inhaled induction of anesthesia because it has a low blood-gas partition 
coefficient and non-pungent odour which facilitates rapid and smooth 
attainment of a depth of anesthesia sufficient for airway procedures.  
 
                          A rapid technique (―single breath‖) in which the patient 
breathes 8% sevoflurane from a primed anesthesia circuit has been used for 
faster induction but it causes apnea more frequently than the incremental 
induction. Inhaled induction of anesthesia is very useful in a wide variety of 
difficult airway conditions.  
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PROPOFOL 
 
 
 
 Propofol belongs to the group of alkylphenols( 2,6-
diisopropylphenol). They are oils and are insoluble in aqueous 
solution but is highly lipid soluble.  
 
 The formulation consists of 1% propofol, 10% soybean oil, 2.25% 
glycerol, and 1.2% purified egg phosphatide. Because of the concern 
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of microbial growth in the emulsion, disodium edetate (0.005%) was 
added for antibacterial action.  
 
 It has a pH of 7 and appears as a slightly viscous, milky white 
substance.  
 
 This formulation can cause pain during injection which can be 
reduced by prior administration of lidocaine (2 mL of 1% lidocaine in 
18 mL propofol).  
 
 Pretreatment with a small dose of opiates, nonsteroidal anti-
inflammatory drugs, ketamine, esmolol/metoprolol, magnesium, 
clonidine/ephedrine combination, dexamethasone, and 
metoclopramide have been studied but with variable efficacy. 
 
 Propofol is used for induction and maintenance of anesthesia and for 
sedation in and outside the operating room.  
 
 Fospropofol, a phosphorylated prodrug of propofol, has a unique 
pharmacokinetic and pharmacodynamic profile. Fospropofol has a 
little longer time for its peak effect and more prolonged 
pharmacodynamic effect compared with propofol. 
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Metabolism  
                             Propofol is rapidly metabolized in the liver by conjugation 
to sulfate and glucuronide which are excreted by the kidneys. Lungs are the 
site of extrahepatic metabolism.  
Pharmacokinetics of propofol. 
 
Elimination Elimination Half-Life (hr) Clearance (mL/kg/min) VdSS (L/kg) 
Propofol 4-7 20-30 2-10 
 
After a single bolus dose, the concentration of propofol in blood decrease 
rapidly as a result of redistribution and elimination. The initial distribution 
half-life of propofol is 2 to 8 minutes. 
 
Cardiovascular effects 
 The major cardiovascular effect of propofol is hypotension which is 
due to reduction in systemic vascular resistance, preload and 
myocardial contractility.  
 Hypotension is more pronounced with propofol than thiopentone and 
it also impairs the baroreceptor reflex. Large dose, rapid injection and 
old age are the factors which exacerbates hypotension.  
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 Changes in cardiac output and heart rate are usually transient in 
healthy patients but can be severe in patients with old age and in 
patients who are on negative chronotropic medications.  
 
 Patients with impaired ventricular function may have a significant 
reduction in cardiac output as a result of reduction in ventricular 
filling pressures and contractility.  
 
 Myocardial oxygen consumption and coronary blood flow decreases 
indicating an imbalance between myocardial oxygen supply and 
demand. 
 
Respiratory effects 
 Propofol is a profound respiratory depressant which usually causes 
apnea following an induction dose.  
 Propofol infusion inhibits hypoxic ventilatory drive and depresses the 
response to hypercarbia.  
 Propofol gives superior jaw relaxation and reduction of pharyngeal 
and laryngeal reflexes than thiopentone which is the reason for its use 
during tracheal intubation or for the placement of laryngeal mask 
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airway in the absence of muscle relaxant. It is not contraindicated in 
asthmatic patients. 
 
Cerebral effects 
 Propofol decreases intracranial pressure due to its action on the 
cerebral blood flow by reducing it.  
 Propofol can cause a critical reduction in cerebral perfusion 
pressure(CPP) < 50 mm Hg in patients with increased intracranial 
tension thus mandating adequate maintenance of mean arterial 
pressure.  
 
 Propofol and thiopental provides  similar degree of cerebral protection 
during focal ischemia. Propofol has antipruritic properties and 
antiemetic effects making it the preferred drug for day care surgery.  
 Propofol has anticonvulsant properties (ie, burst suppression), it has 
been successfully used to terminate status epilepticus, and can be 
safely administered to epileptic patients. Tolerance does not develop 
after long-term propofol infusions. 
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Drug Interactions 
                               Fentanyl and alfentanil concentrations may be increased 
by concomitant administration of propofol.  
 
Dosage of Intravenous Propofol 
 
Induction of general 
anesthesia 
1-2.5 mg/kg IV dose reduced with increasing age 
Maintenance of general 
anesthesia 
50-150 µg/kg/min IV combined with N2O or an 
opiate 
Sedation 25-75 µg/kg/min IV 
Antiemetic dose 
10-20 mg IV, can repeat every 5-10 min or start 
infusion of 10 µg/kg/min 
 
Uses  
 
 Propofol, when used for induction of anesthesia in briefer procedures, 
results in a significantly quicker recovery and an earlier return of 
psychomotor function compared with thiopental.  
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 Propofol provides a rapid recovery and is superior to barbiturates for 
maintenance of anesthesia, and it seems to be equal to enflurane, 
isoflurane and sevoflurane.  
 
 
 When combined with propofol, the required infusion rate and 
concentration of opioids is reduced. Because opioids alter the 
concentration of propofol required for adequate anesthesia, the 
relative dose of either opioid or propofol markedly affects the time 
from termination of drug to awakening and recovery.  
 
Side Effects and Contraindications  
                                    Induction of anesthesia with propofol is associated 
with several side effects which includes:  
 Hypotension 
 Pain on injection  
 Myoclonus 
 Respiratory depression   
 Thrombophlebitis.  
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Intravenous induction  
 Propofol is the intravenous induction agent which attenuates the 
pharyngeal and laryngeal reflexes which is the reason for its use 
during tracheal intubation or for the placement of laryngeal mask 
airway in the absence of muscle relaxant.  
 Studies indicate that when propofol is combined with opioids, 
acceptable intubating conditions is obtained.  
 Either increasing the propofol dose to 2.5 or 3 mg/kg or increasing the 
dose of fentanyl to 2 – 3 µg/kg would provide excellent intubating 
conditions in patients. Disadvantage is the exacerbation of 
hypotension and apnea associated with the high dosage.  
 
 
                            De Fatima et al. reported that fentanyl 3 microgram/kg  
given 5 min prior to induction of propofol 3 milligram/kg resulted in 
acceptable intubation conditions in 75% of patients. This was compared with  
propofol 2.5 mg/kg and 3.5 mg/kg where the acceptable intubating 
conditions were 20% and 80% respectively. Hence they concluded that 
propofol 3 mg/kg and fentanyl 3 µg/kg was the ideal dose for tracheal 
intubation without muscle relaxants.  
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FENTANYL 
 
Mechanisms of Action 
                                    Opioids bind to specific receptors which are located 
throughout the central nervous system and other tissues. Four major types of 
opioid receptor have been identified : mu, kappa , delta, and sigma . 
  
                                    Opioids are effective in producing analgesia though 
they provide only minimal degree of sedation, The pharmacodynamic 
properties of specific opioids depend on which receptor is bound, the 
binding affinity, and whether the receptor is activated.  
 
                                    Opioids inhibit the presynaptic release and 
postsynaptic response to excitatory neurotransmitters from nociceptive 
neurons. Pain impulses could be interrupted at the level of the dorsal horn of 
the spinal cord with intrathecal or epidural administration of opioids. 
Modulation of a descending inhibitory pathway from the periaqueductal gray 
through the nucleus raphe magnus to the dorsal horn of the spinal cord also 
plays a role in opioid analgesia.  
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Pharmacokinetics 
 Oral transmucosal fentanyl citrate absorption is an effective method of 
producing analgesia and sedation and provides rapid onset (10 min) of 
analgesia and sedation in children (15–20 µg/kg) and adults (200 – 
800 µg/kg).  
 Fentanyl is lipid soluble which is the reason for its rapid onset and 
short duration of action. 
 Most opioids depend primarily on the liver for biotransformation.  
 The lungs exert a significant first-pass effect and transiently take up 
approximately 75% of an injected dose of fentanyl. Approximately 
80% of fentanyl is bound to plasma proteins, and significant amounts 
(40%) are taken up by red blood cells. 
 They have a high hepatic extraction ratio, hence their clearance 
depends on liver blood flow. 
 
Effects on Organ Systems 
 Opioids impair cardiovascular function very minimally.  
 High doses of fentanyl are associated with a vagus-mediated 
bradycardia 
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 Opioids depress ventilation, especially the  respiratory rate. Resting 
PaCO2 increases and the response to a CO2 challenge is attenuated, 
resulting in a shift of the CO2 response curve downward and to the 
right.  
 The apneic threshold—the highest PaCO2 at which a patient remains 
apneic is elevated on administration of opioids, and hypoxic drive is 
decreased.  
 Opioids can induce chest wall rigidity severe enough to prevent 
adequate ventilation. This effect is centrally mediated and occurs most 
often after large bolus dose and it can be effectively treated with 
muscle relaxants. Opioids can effectively attenuate the intubation 
response due to laryngoscopy.   
 Opioids reduce cerebral oxygen consumption, cerebral blood flow, 
and intracranial pressure, although less than barbiturates or 
benzodiazepines. 
 Opioids slow gastric emptying time by reducing peristalsis. Biliary 
colic may result from opioid-induced contraction of the sphincter of 
Oddi. 
 Opioids reduce the stress response to surgical stimulus. 
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USES: 
 For analgesia – bolus dose of 2 - 6 µg/kg and Infusion rates range 
from 0.01 to 0.05 µg/kg/min.  
 Opioids interact synergistically and it reduces the dose of propofol 
and other sedative-hypnotics required for loss of consciousness and 
during noxious stimulation such as skin incision.  
 The purpose of using opioids was producing anesthetic conditions 
with hemodynamic stability.  
 The plasma concentration of fentanyl required for postoperative 
analgesia was approximately 1.5 ng/mL. 
 The MAC requirement of various volatile agents are reduced by 
opioid administration.  
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REVIEW OF LITERATURE 
 
The literature was searched and the studies which were conducted 
comparing inhalational induction with sevoflurane and intravenous induction 
with propofol in elective patients undergoing general anesthesia was 
reviewed.  
1. Karaaslan et al. compared whether propofol and sevoflurane with 
remifentanil without muscle relaxant would yield equivalent 
intubation conditions.  
                            80 patients of ASA physical status I,II were 
randomly allocated into 2 groups. Patients were induced with 
sevoflurane 8 %  in group 1 and propofol 1 milligram/kg/min in group 
2 until bispectral index was less than 60. Intubation was done when 
BIS was < 60. All patients received remifentanil infusion at a dose of 
1 µg/kg/min.  
                           Intubating conditions assessment were graded as 
excellent, good, marginal, poor using vocal cord opening, limb 
movement and jaw relaxation. Heart rate and mean arterial blood 
pressure were recorded before induction, and during induction, and  
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1 min after intubation, 2 after intubation and 5 minutes following 
intubation. The duration of time for bispectral index to become  less 
than 60 was recorded. 
                        Optimal intubating conditions were better in group II 
compared with group I - 90% vs 45%. The ratio of patients showing 
successful ratio(optimal or good) intubating conditions was 80% and 
100% in groupI and group II .  
                        The duration of time required for bispectral index to 
become less than 60 was reduced in group II than in group I 
(47.1±27.2 sec vs. 111.9±60.6 sec). Mean arterial pressure and heart 
rate showed a significant decrease compared to baseline in both the 
groups.  
               They concluded that under BIS monitoring, propofol and 
remifentanil offered better intubation conditions and shorter induction 
period compared with sevoflurane and remifentanil. 
(J Clin Exp Invest Vol 2, No 2, June 2011.) 
2. Scheller et al. compared propofol at a dose of 2 mg/kg with different 
doses of alfentanil 30, 40, 50, or 60 µg/kg for tracheal intubation 
without muscle relaxant to evaluate airway and the intubating 
conditions.  
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                              75 patients with ASA I or II with Mallampati grade 
I airway were chosen. Patients were randomly assigned into 5 groups. 
There were 15 patients in each group. Patients in group I received 
thiamylal 4 mg/kg, tubocurare 3 mg and succinylcholine 1 mg/kg. 
Patients in groups II-V received propofol at a dose of 2 mg/kg with 
different doses of alfentanil 30, 40, 50, or 60 µg/kg. Muscle relaxant 
was avoided in groups II-V.  
                               Jaw mobility and ease of ventilation were 
recorded. 90 seconds after induction, laryngoscopy was done and the 
glottic exposure and the vocal cord position were recorded. Patient 
response was noted after intubation. Heart rate and arterial blood 
pressure were recorded before and after induction, and after intubation 
of the trachea. 
                           Ease of ventilation was good and jaw was relaxed in 
all the patients. 5 patients in group II(30 µg/kg) couldn’t be intubated 
because of poor exposure or closure of vocal cords. In all other 
groups, position of vocal cord was favorable for intubation compared 
with group II.  
                          Heart rate and arterial blood pressure had a significant 
decrease after induction compared with preinduction values. But there 
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were no difference between the alfentanil groups. Patients in group I 
had significant increase in heart rate after induction compared with 
preinduction values. Patients in group I had significant rise in mean 
arterial pressure after laryngoscopy and intubation compared with 
postinduction values.  
                             They concluded that patients receiving propofol for 
induction and alfentanil(>30 µg/kg),mask ventilation,jaw mobility, 
vocal cord position and exposure during laryngoscopy and patient 
response to intubation differs minimally compared with thiamylal and 
succinylcholine. 
( Anesth Analg 1992; 75; 788-793.) 
3. Grant et al. assessed the intubating conditions in adults with propofol 
induction and varying doses of remifentanil.  
                            60 patients of ASA  I or II were randomly assigned 
into 3 groups. They assessed the intubating conditions in three groups 
after induction with propofol 2 mg/kg and various doses of 
remifentanil. Remifentanil doses given were 0.5, 1.0 or 2.0 µg/kg. 
Ease of laryngoscopy, jaw relaxation, coughing, position of vocal 
cords and limb movement were  assessed. 
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                           Success rate of intubation was 80%, 90% and 100% 
with remifentanil doses of 0.5, 1.0 or 2.0 µg/kg respectively. 
Acceptable intubating conditions were present in 20%, 50% and 80% 
of patients. All three groups had a reduction in arterial blood pressure 
post induction but there was no difference between groups.  
                           They concluded that the intubating conditions were 
better after induction with propofol at a dose of 2 mg/kg and 
remifentanil at a dose of 2 µg/kg.  
(Br. J. Anaesth. (1998) 81(4): 540-543 )  
4. Sivalingam et al. studied the intubating conditions and the 
hemodynamic changes after induction of sevoflurane nitrous oxide in 
3 different doses of alfentanil with low-dose alfentanil and 
suxamethonium.  
                             Patients were randomly assigned into four groups. 
They assessed the intubating conditions after inducing the patient with 
vital capacity breaths of sevoflurane 8% and  60 % nitrous oxide in 4 
groups receiving alfentanil of 20, 25, 30 µg/kg and alfentanil 10 µg/kg 
and succinylcholine 1 mg/kg.  
                           Intubating conditions were excellent in 83%, 80%, 
92% and 96% of patients in groups with alfentanil 20, 25, 30 µg/kg 
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and alfentanil 10 µg/kg and succinylcholine 1 mg/kg respectively. 
Laryngoscopy and tracheal intubation induced increase in heart rate 
significantly decreased in all the groups.  
                           There was a significant decrease in mean arterial 
pressure after induction in all groups. Mean arterial pressure increased 
significantly 2 minutes after intubation compared with post induction 
value in alfentanil with succinylcholine group.  
                           They concluded that the intubating conditions 
obtained with sevoflurane plus alfentanil 30 µg/kg were comparable 
to those provided by the sevoflurane, alfentanil 10 µg/kg and  
suxamethonium combination.  
(Anaesth Intensive Care. 2001 Aug;29(4):383-7) 
5.  Katoh et al. aimed at determining the effect of fentanyl 
administration before tracheal intubation on the MAC-TI of 
sevoflurane.  
                             80 patients of ASA I or II were randomized into 4 
fentanyl groups – 0, 1, 2 ,4 µg/kg. This study was done to determine 
whether fentanyl would affect sevoflurane requirement for achieving 
50% probability of nil movement in response to laryngoscopy and 
intubation (MAC-TI). All the patients were induced with sevoflurane 
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at a pre-selected end-tidal concentration according to dixon’s up and 
down technique.  
                            Fentanyl administered after steady state sevoflurane 
concentration was maintained for at least 10 min and tracheal 
intubation was done 4 min after administration of fentanyl, and 
patients were assessed for movement. Heart rate (HR) and mean 
arterial pressure (MAP) were recorded before induction, fentanyl 
administration, laryngoscopy and after intubation.  
                         The authors found no difference in the sevoflurane 
requirement significantly between fentanyl 2 and 4 µg/kg indicating  
that fentanyl has a ceiling effect. The MAC-TI of sevoflurane in this 
study was 3.55% (95% confidence intervals 3.32-3.78%), and this was 
reduced to 2.07%, 1.45% and 1.37% by addition of fentanyl 1, 2 and 4 
µg/kg. Fentanyl attenuated heart rate and MAP (mean arterial blood 
pressure) due to intubation which was dose dependent even with 
decreasing concomitant sevoflurane concentration. Fentanyl 4 µg/kg 
attenuated the hemodynamic changes(HR and MAP) more effectively 
than fentanyl 1 or 2 µg/kg at sevoflurane concentrations close to 
MAC-TI.  
(Br J Anaesth. 1999 Apr;82(4):561-5.) 
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6. Kimura et al. aimed at determining the concentration of sevoflurane 
required for mean alveolar concentration(MAC) and for tracheal 
intubation (MAC-TI) in adults.  
                             86 elective patients of ASA physical status I and II 
were selected. After maintaining the pre-selected end tidal 
concentration of sevoflurane for 20 min, intubation was done without 
muscle relaxant for MAC-EI determination. Pre-determined 
concentration sevoflurane at which intubation was done was - 2.5%, 
3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, and 7.0%. After 
maintaining the pre-selected end tidal concentration of sevoflurane for 
20 min, skin incision was attempted. Pre-determined concentration 
sevoflurane at which skin incision was attempted was 0.5%, 1.0%, 
1.5%, 2.0%, 2.5%, and 3.0%.  
                          They determined the MAC-EI of sevoflurane to be 
4.52% (95% confidence limits, 3.91%-5.21%), and the ED95 
for tracheal intubation was 8.07%. The MAC of sevoflurane was 
1.58% (95% confidence limits, 1.14%-1.98%), and the AD95 
(anesthetic ED95) was 2.96%. The MACEI/MAC ratio was 2.86 (95% 
confidence limits, 2.63-3.43).  
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                           They concluded that induction followed by tracheal 
intubation without muscle relaxant can be accomplished in adults 
when sevoflurane is given as a single anesthetic but in excess of 
8% end-tidal concentration.  
(Anesth Analg August 1994 79:378-381.) 
7. Van Twest et al. assessed the effectiveness of bispectral index 
monitoring as a guide to the time of intubation during sevoflurane 
induction without the use muscle relaxants in adults, and to determine 
whether a bispectral index value of 25 would yield better intubating 
conditions than a bispectral index of 40.  
                          Forty patients were randomized into two groups, a 
target bispectral index of 25 or a target bispectral index of 40.  
Patients were premedicated with midazolam 20 µg/kg, fentanyl 0.5 
µg/kg. Induction with Sevoflurane was initiated and titrated to reach 
the target BIS value and maintained within the target range for two 
minutes. The trachea was intubated and the intubating conditions were 
assessed.  
                            The bispectral index 25 group had a superior median 
intubating score of 4 (range 3-9) compared with the Bispectral index 
40 group with a median of 7 (5-10, [6-9], P<0.001). The time to reach 
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target BIS values was not statistically different (BIS 25 group - 6.6 
min, BIS 40 group - 5.1 min, P=0.054).  
                           End-tidal sevoflurane concentration upon reaching 
the target BIS was higher in the BIS 25 group (5.3% +/- 1.2%) vs the 
BIS 40 group (3.5% +/- 0.95) (P<0.001). There was no statistical 
difference in the heart rate and arterial blood pressure between the 2 
groups. 
                           They concluded that target Bispectral index value of 
25 provides better intubating conditions than target Bispectral index 
value of 40 during induction with sevoflurane without neuromuscular 
blocking agents.  
(Anaesth Intensive Care. 2006 Oct;34(5):606-12.) 
8. Taha et al.  compared the intubation conditions and hemodynamic 
changes after induction and tracheal intubation in patients who were 
either propofol – remifentanil - lidocaine or thiopental – remifentanil - 
lidocaine.  
                            The study group consisted of 76 healthy patients 
who were randomly allocated into 2 groups: group P received and 
propofol at a dose of 2 mg/kg, remifentanil 2 μg/kg and lidocaine 1.5 
mg/kg, or group T received thiopental 5 mg/kg, lidocaine 1.5 mg/kg, 
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remifentanil 2 μg/kg. Laryngoscopy and intubation was done 90 
seconds after administration of the hypnotic agent.  
                            Intubation conditions were determined as excellent, 
good or poor with jaw relaxation, ease of ventilation, vocal cord 
position, and the patient’s response to intubation and tracheal cuff 
inflation. Heart rate and mean arterial pressure was measured 45 
seconds after induction, after intubation, 2 and 5 min after intubation. 
                           Intubation conditions were excellent in 50% and 84% 
of Group T and Group P patients which was statistically significant. 
The reduction in MAP (mean arterial pressure) from baseline to post 
induction was significantly higher in group P (27.4% ± 11.6 ) 
compared with group T  (21.8% ± 10.0) and from baseline to post 
intubation in group P (19.0% ± 16.7 ) and group T (vs 11.2% ± 14.9) 
were also statistically significant. 
                              The change in % from baseline HR was statistically 
significant and higher in Group P (13.8% ± 9.7) than in Group T 
(0.5% ± 12.4) after induction, after intubation (8.7% ± 13.7 in group P 
vs 2.1% ± 13.1 in group T), and 2 minutes after intubation (7.04% ± 
14.3 in group P vs 3.5% ± 14.3 in group T). 
 38 
 
                             They concluded that propofol-remifentanil-
Lidocaine was better than thiopentone- remifentanil – lidocaine for 
tracheal intubation without neuromuscular blocking agents. Although 
it causes more hemodynamic instability.  
(Can J Anaesth. 2005 Mar;52(3):249-53.) 
9. Stevens et al. compared different doses of remifentanil with propofol 
induction for tracheal intubation without neuromuscular relaxants.  
                           80 premedicated outpatients belonging to ASA I and 
II were randomized into four groups. Remifentanil 1, 2, 3, or 4 µg/kg 
was infused intravenously over 90 seconds in group I -IV. 60 seconds 
after starting remifentanil infusion, Propofol at a dose of  2 mg/kg 
over 5 seconds was given. Laryngoscopy and tracheal intubation were 
assessed 90 seconds after administration of propofol.  
                          Clinically optimal intubation conditions were defined 
as open vocal cords,  jaw relaxation, and the presence of < 2 coughs as 
intubation response were observed. This was seen in 35% of patients 
in group I, 75% of pateints in group II, 100% of patients in group III, 
and 95% of patients in Groups IV respectively.  
                         Intubating conditions that was clinically acceptable 
were significantly less in Group I compared with other groups. 
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Excellent intubating conditions were observed in 30% of patients in 
group I, 50% of patients in group II, 80% of patients in group III, and 
80% of patients in Groups IV respectively. Groups III and IV had 
better intubating conditions compared with Groups I and II.  
                        The average time for resuming to spontaneous 
ventilation after induction with propofol was less than 5 min in all 
groups. The percentage of decrease in mean arterial pressure was 
16%, 20%, 28%, 26% in group I, II, III, IV immediately before 
tracheal intubation.  
                            They concluded that premedicated patients with 
favorable airway can be intubated with excellent or good intubating 
conditions 90 seconds after the administration of propofol 2 mg/kg 
and remifentanil 3-4 µg/kg. Remifentanil at a dose of 3 µg/kg and 
propofol at a dose of  2 mg/kg administered in combination  may 
provide acceptable conditions for tracheal intubation without muscle 
relaxant. This combination allows the rapid return of spontaneous 
ventilation. 
(Anesth Analg 1998; 86: 45–9.) 
10. Thwaites et al. compared sevoflurane versus propofol with  
succinylcholine for intubation.  
 40 
 
                            The study group consisted of 64 healthy children of 
age group 3 to 10 yrs who underwent  adenotonsillectomy. Induction 
was done using either 8% sevoflurane in nitrous oxide or propofol at a 
dose of 3 to 4 mg/kg with succinylcholine at a dose of 2 mg/kg and 
intubation was performed 150 seconds after induction.  
                            Intubating conditions were scored using Krieg and 
Copenhagen Consensus Conference (CCC) scores. The trachea was 
successfully intubated at the first attempt in all patients under 
clinically acceptable conditions but the scores were significantly 
better with propofol and succinylcholine.  
(Br J Anaesth. 1999 Sep;83(3):410-4.) 
11. Tsuda et al. evaluated tracheal intubation without muscle relaxant 
with propofol and different doses of fentanyl.  
                           55 adults posted for elective surgery were 
randomized into four groups and they received fentanyl doses of 0, 2, 
3, or 4 µg/kg respectively. 3 minutes after fentanyl administration, 
propofol at a dose of 2 mg/kg was given for induction. After the loss 
of consciousness, supplementation with topical lidocaine at a dose of 
2 mg/kg was done. Laryngoscopy and tracheal intubation were done 
after topical lidocaine administration.  
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                           Patients without administration of fentanyl had poor 
intubating conditions. The incidence of movement and persistent 
coughing with laryngoscopy and intubation were reduced with 
increasing doses of fentanyl. Visualization of the vocal cord was more 
likely to be impossible in patients in fentanyl 4 µg/kg group (40%) 
compared with patients in fentanyl 2 µg/kg group (7%).  
                          There were no significant differences among groups 
receiving different doses of fentanyl with respect to position of vocal 
cords . The vocal cords were closed in 26% of patients receiving 
fentanyl and propofol for intubation.  
(Masui. 2001 Oct;50(10):1129-32.) 
12. Bonnin et al. compared target controlled infusion of propofol and 
sevoflurane for fiberoptic intubation under spontaneous ventilation.  
                            52 patients belonging to ASA I-II were randomized 
into two groups. Patients were pre-oxygenated for 3 min and they 
received either tidal volume ventilation with sevoflurane 4% or 
propofol infusion with a target plasma concentration of 4 mg/l. After 2 
min, sevoflurane was increased by 1% every 2 min and propofol 
infusion was increased by 1 mg/l until there was no reaction during 
mandibular movement.  
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                          This concentration was maintained for 4 min before 
starting nasotracheal fiberoptic intubation. Oxygen Saturation, heart 
rate, mean arterial pressure, bispectral index(BIS) were monitored 
during induction and fiberscopy. The quality of intubation and 
operator satisfaction were assessed.  
                           There was no difference in BIS values or pulse 
oximetry during or at the end of induction. Desaturation occurred 5 
times during fibreoptic intubation in propofol group and none with 
sevoflurane group.  
                         They concluded that sevoflurane provides good 
intubating conditions in patients undergoing fiberoptic intubation 
without any hypoxemic episodes in spontaneously breathing patients 
similar to those observed with propofol. 
 ( Acta Anaesthesiol Scand. 2007 Jan;51(1):54-9.)  
13. Striebel et al. compared the intubation conditions using propofol and 
fentanyl without muscle relaxant with the combination of propofol, 
fentanyl ,succinylcholine and sodium thiopental/succinylcholine. 
                           100 patients of ASA physical status I and II 
undergoing gynecological surgery were randomized into 4 groups: 
Group 1 received 100 µg/kg fentanyl, dose of sodium thiopental was 
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demand adapted,1 mg vecuronium, and succinylcholine 1 mg/kg; 
Group 2 received 100 µg/kg fentanyl and dose of propofol was 
demand adapted ; 
Group 3 received 200 µg/kg fentanyl and dose of propofol was 
demand adapted;  
Group 4 received 100 µg/kg fentanyl, 1 mg vecuronium, dose of 
propofol was demand adapted and succinylcholine 1 mg/kg.  
          
                            Jaw relaxation, glottis visualization, position and 
movement of vocal cords and patient movement were assessed. 
Intubation was graded as I-IV by the anaesthetist. Postoperatively all 
the patients were asked regarding muscle pain which was graded from 
I - IV. Before, during and after endotracheal intubation, heart rate, 
arterial blood pressure and arterial haemoglobin oxygen saturation 
were monitored.  
                         Group I required an average of 5.5 ± 1.2 mg/kg 
sodium thiopentone. There were no significant differences in group 
II, III, IV when compared with the dose of propofol which was 2.4, 
2.2 and 2 mg/kg. There was no difference with regard to jaw 
relaxation, glottis visualization and patient movement during 
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intubation between the groups. Statistically significant difference 
occurred with regard to the movement and position of vocal cords 
during intubation (group III was worse than groups I, II, IV) and the 
patient movement 1 min after intubation (group 2 was worse than 
group 3). Overall assessment of intubation was worse in group III 
than group II, IV. Muscle pain experienced postoperatively was 
worse in group I than group II, III.  
                          They concluded that the use of 100 µg fentanyl, 
thiopentone sodium and succinylcholine had intubating conditions 
which was comparable with 100 µg fentanyl plus propofol.  
( Anaesthesist. 1995 Dec;44(12):809-17.) 
14. Gore et al. evaluated intubating conditions with propofol given at 
different doses without neuromuscular blocking agents.  
                          90 patients of ASA I and II patients who were posted 
for elective surgery were randomly allocated into 3 groups. group I 
was given propofol 2 mg/kg,  group II 2.5 mg/kg, group III 3mg/kg. 
After premedicating the patient with fentanyl and midazolam and 5 
minutes thereafter, propofol was given followed by lignocaine 90 
seconds before intubation. Intubation conditions and hemodynamic 
changes were recorded . 
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                            Intubation conditions were excellent in 96.7% of 
patients in propofol 2.5 mg/kg group and 100% in propofol 3 mg/kg 
group. They identified that clinically acceptable intubating conditions 
could be achieved with propofol at a dose of 2.5 mg/kg and 3 mg/kg 
without significant hemodynamic changes and 100% success could be 
obtained with 3 mg/kg of propofol.  
                         They concluded that ideal intubating conditions 
without neuromuscular blocking agents could be achieved with 
propofol 3 mg/kg, lignocaine 1.5 mg/kg and fentanyl 2 µg/kg without 
significant hemodynamic alterations. 
( J Anaesth Clin Pharmacol 2011;27:27-30.) 
15. Ko et al. aimed at determining the optimal time of injection of 
fentanyl during induction to reduce hemodynamic response to 
laryngoscopy and tracheal intubation.  
                           150 patients were randomized into 5 groups. group I 
was the control group in which the patient was not given fentanyl. 
Groups II – V received fentanyl at a dose of 2 µg/kg 1, 3, 5, or 10 min 
before tracheal intubation, respectively.  
                             Blood pressures were not increased in Groups III 
and IV, except for rise of diastolic blood pressure in Group III, which 
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was significant after intubation compared with the baseline values. 
Group I, group II, and group V showed rise in in arterial blood 
pressure which was significant.  
                            Systolic pressure, diastolic pressure, and mean 
arterial pressure 1 min after intubation in Group III and group IV were 
less compared to those in the control group. Heart rate increase in 
group IV was significantly less compared to the control group but 
there was no significant difference in Group II, group III, and group 
V. The number of patients with dysrhythmia and tachycardia was 
significantly lesser in Group IV than in the control group.  
                           They concluded that the optimal time of injecting 
fentanyl to attenuate hemodynamic response to laryngoscopy and 
tracheal intubation is 5 min before tracheal intubation.  
(Anesth Analg 1998; 86: 658–61) 
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METHODOLOGY 
 
                                      After obtaining institutional ethical committee 
clearance and written informed consent from each patient, 80 patients of 
ASA physical status I and II scheduled for elective surgery undergoing 
general anesthesia were included in the study.  
 
                                      It was a prospective, randomised, single blinded 
study conducted in the Department of Anaesthesiology, Rajiv Gandhi 
government general hospital, Chennai.  The patients who were satisfying the 
inclusion criteria were enrolled in the study. The patients were randomly 
allocated into two groups through lots before administering general 
anesthesia. 
                                       Patients were divided into 2 groups, group S (n=40) 
comprised of patients who were given sevoflurane induction and group P 
(n=40) comprised of patients who were given propofol induction. 
 
INCLUSION CRITERIA: 
 Age : 15 years and above 
 ASA : I & II 
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 Elective surgery undergoing general anesthesia 
 Mallampatti scores : I & II 
 Who have given valid informed consent 
 
EXCLUSION CRITERIA: 
 Not satisfying inclusion criteria 
 Patients posted for emergency surgery 
 Patients with difficult airway 
 Lack of written informed consent 
 Neuromuscular disorders 
 Cervical cord injuries 
 Severe cardiovascular, central nervous system, hepatic and renal 
disease 
 Patients with increased risk of regurgitation 
 Anticipated difficult airway 
 Reactive airway disease 
 History of drug allergy to the study drugs 
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MATERIALS: 
• Laryngoscopes of various sizes,  
• Gum elastic bougie 
• Guedel’s oropharyngeal airway 
• Drugs –  propofol, sevoflurane, fentanyl, glycopyrrolate, 
xylocard, normal saline, inj ephedrine, inj atropine, 
succinylcholine and other emergency drugs. 
• Monitors – ECG,NIBP,SPO2,EtCO2 
• 2 cc,5 cc and 10 cc syringe 
• 18G intravenous cannula. 
• Appropriate size endotracheal tubes 
 
PRIMARY OUTCOME MEASURES:    
 Intubating conditions  
 Coughing after intubation and cuff inflation 
 Cormack lehanne grading 
 Apnea after induction 
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SECONDARY OUTCOME MEASURES:  
 Heart rate 
 Systolic blood pressure  
 Diastolic blood pressure 
 Mean arterial pressure  
 
All these parameters were measured at  
 Baseline 
 Induction  
 Immediately after intubation 
 1 minute after intubation  
 5 minute after intubation. 
 
Assessment of Intubating conditions were done using 3 variables :  
 
1. Jaw relaxation 
2. Vocal cord position 
3. Patient movement during and within 1 min of attempted intubation of 
the trachea. 
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Intubating conditions score : 
 
SCORE JAW 
RELAXATION 
VOCAL CORD 
POSITION 
INTUBATING 
RESPONSE – 
LIMB 
MOVEMENT 
OPTIMAL Fully relaxed Widely open None  
GOOD Mild resistance Mid position  Slight  
POOR Tight but open Moving but open Moderate  
INADEQUATE Impossible  Closed  Severe  
 
Coughing after intubation and cuff inflation was graded as: 
 None  
 Mild  
 Moderate  
 Severe  
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Cormack and lehanne grading was graded as : 
1 - Visualization of entire vocal cords 
2 - Visualization of posterior part of laryngeal aperture 
2a - Visualization of posterior part of vocal cords 
2b - Visualization of arytenoids only 
3 - Visualization of epiglottis 
3a – epiglottis liftable 
3b – epiglottis adherent or only tip visible 
4 - No glottis structures seen 
 
Heart rate,systolic blood pressure and diastolic blood pressure, mean 
arterial pressure was measured: 
 Baseline  
 After Induction  
 Immediately after intubation 
 1 minute after intubation 
 5 minute after intubation 
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CONDUCT OF THE STUDY: 
                                   The patients enrolled in the study were given 
Diazepam 10 mg per oral, ranitidine 100 mg per oral and metoclopramide 10 
mg per oral 3 hours prior to surgery as premedication. The patients were 
randomly assigned into two groups through lots before administering general 
anesthesia. Patients were divided into 2 groups, group S (n=40) comprised 
of patients who were given sevoflurane induction and group P (n=40) 
comprised of patients who were given propofol induction.  
 
                                All patients were premedicated with Inj. Ondansetron 4 
mg iv, Inj.glycopyrrolate 0.2 mg iv in the pre anaesthesia room. After the 
patient entered the theatre, the patient was placed in the supine position with 
the head in magill’s position.  
 
                                   The patient’s vital parameters were monitored using 
electrocardiogram, non-invasive blood pressure measurements and pulse 
oximetry. The baseline vital parameters were noted and an 18 gauge cannula 
was started in the dorsum of hand and 0.9% normal saline of 10 ml/kg was 
infused in all patients before induction.  
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                                 The facemask was connected to a semiclosed anesthetic 
circuit and preoxygenation with 100 % oxygen were done in all patients for 
5 min through a face mask which is tight fitting. All patients received 
fentanyl intravenously at a dose of 2 µg/kg 5 minutes before induction and 
lignocaine 1.5 mg/kg intravenously 90 seconds before tracheal intubation.  
                             Patients in group P (n=40) received propofol intravenously 
at a dose of 3  mg/kg over 10 seconds and the anesthesiologist performed the 
laryngoscopy and tracheal intubation 90 seconds after propofol 
administration.  
 
                             Patients in group S (n=40) received sevoflurane induction. 
The fresh gas flow(FGF) was set at 6 litres/minute with oxygen and nitrous 
oxide ratio of 40% : 60 % and the patient breathed through a primed 
breathing circuit with sevoflurane spontaneously starting with the dialed 
concentration of sevoflurane at 1% and increasing it by 1% every 2 – 3 
breaths until the dialed concentration of vaporizer is 8% and the ventilation 
was assisted to maintain etCO2 between 25 and 35 mmHg.    
               
                            Tracheal intubation was performed 5 minutes from the start 
of induction. Laryngoscopy was performed using macintosh blade size 3 and 
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the anesthesiologist performing the laryngoscopy and intubation would score 
the intubating conditions as optimal, good, poor, inadequate according to the 
degree of jaw relaxation, vocal cord position and intubating response.  
 
                                 The patients were intubated with appropriate sized 
Cuffed endotracheal tubes in both males and females. After tracheal 
intubation, the tracheal cuff was gently inflated, and anesthesia was 
maintained with reduced concentration (2%) of sevoflurane in group S and 
with propofol infusion of 4 mg/kg/hr in group P.  
 
                                   Cough after intubation and after cuff inflation was  
graded by the anesthesiologist as none, mild, moderate and severe. Cormack 
lehanne grading and the occurrence of apnea any time during induction was 
also specified by the anesthesiologist.  
 
                                  Hemodynamic parameters such as heart rate, systolic, 
diastolic and mean arterial pressure was measured after induction, 
immediately, 1 minute and 5 minutes after intubation.  
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                                When the trachea couldn’t be intubated due to 
unacceptable intubating conditions or severe coughing or airway obstruction, 
succinylcholine was given at a dose of 1 mg/kg intravenously and then 
tracheal intubation was done.  
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STATISTICAL ANALYSIS 
 
 Results are expressed as mean and standard deviation. All statistical 
analyses were carried out using SPSS for Windows version 15.0.  
 
 Statistical analysis was carried out student's t-test for parametric data 
and chi square test, fischer’s exact test for non parametric data.  
 
 
 Heart rate, systolic, diastolic and mean arterial pressure were 
compared using student’s t-test. Intubation scores were compared 
using fischer’s exact test.  
 
 A p value < 0.05 was considered as statistically significant. 
 
  From the data of previous studies, a 30% difference in acceptable 
intubating conditions between two groups was used for power 
analysis.  
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 Also, a type I error of 0.05 as well as a type II error of 0.20 were used 
in the power analysis. The results of the power analysis showed that a 
sample size of 38 patients was needed in each group.  
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OBSERVATION AND RESULTS: 
 
 
There were no significant difference in terms of age, sex ,height and weight 
between the two groups. the demographic data is shown in table 1. 
 
Table 1: Demographic data 
 Propofol(group 1) Sevoflurane(group  2) P value 
Age  
 
Weight  
 
Height  
 
Sex 
Male  
 
female 
32   12.43 
 
57   9.63 
 
157.5   6.08 
 
 
18 
 
22 
33.4   11.48 
 
58.12   8.96 
 
158.75   5.99 
 
 
16 
 
24 
0.602 
 
0.590 
 
0.376 
 
Intubating conditions score: 
The intubating conditions score are depicted in table 2.  
 Optimal intubating conditions were present in 21/40 (52.5%) of 
patients in group P and 37/40 (92.5%) of patients in group S (P – 
0.0001).  
 Good intubating conditions were present in 12/40 (30%) of patients in 
group P and 3/40 (7.5%) of patients in group S.  
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 The acceptable intubating conditions as defined by optimal or good 
intubating conditions were present in 33/40 (82.5%) of patients in 
group P and 40/40 (100%) of patients in group S (P – 0.011).  
 
  Poor intubating conditions were present in 6/40 (15%) of patients in 
group P whereas there was none in group S.  
 
 There was one patient in group P who had inadequate intubating 
conditions who was intubated with succinylcholine because of tight 
jaw, closed vocal cords, and severe coughing following laryngoscopy. 
 
Table 2: Intubating conditions score 
 
 PROPOFOL SEVOFLURANE P VALUE 
Int.conditions 
 
OPTIMAL 
 
GOOD 
 
POOR 
 
INADEQUATE 
 
SUCCESS 
RATIO 
(optimal or good) 
 
 
21 (52.5%) 
 
12 (30%) 
 
6 (15%) 
 
1 (2.5%) 
 
33 (82.5%) 
 
 
37 (92.5%) 
 
3 (7.5%) 
 
  -  
 
  - 
 
40 (100 %) 
 
 
0.0001* 
 
 
 
 
 
 
 
0.011* 
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Cough after intubation and cuff inflation: 
 
 There was no cough after intubation in 62.5% of patients in group P 
and 90% of patients in group S (P – 0.026).  
 
 There was mild coughing or diaphragmatic movement in 20% of 
patients in group P and 7.5% of patients in group S.  
 
 
 There was moderate or severe coughing in 17.5% in group P and 2.5% 
in group S.  
 
 There was no cough after cuff inflation in 47.5% of patients in group 
P and 75% of patients in group S (P – 0.013).  
 
 There was mild cough after cuff inflation in 30% of patients in group 
P and 22.5% of patients in group S.  
 
 
 Moderate or severe cough after cuff inflation in group P and S were 
22.5% and 2.5%. The data of cough after intubation and cuff inflation 
are shown in table 3. 
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Table 3: Cough after intubation and cuff inflation 
 
 
 
 PROPOFOL SEVOFLURANE P VALUE 
Cough after intubation 
 
 
NONE 
 
MILD 
 
MODERATE  
 
SEVERE 
 
 
 
25 (62.5%) 
 
8 (20%) 
 
6 (15%) 
 
1 (2.5%) 
 
 
 
36 (90%) 
 
3 (7.5%) 
 
1 (2.5%) 
 
   - 
 
 
 
0.026* 
Cough after cuff 
inflation 
 
 
NONE 
 
MILD 
 
MODERATE  
 
SEVERE 
 
 
 
 
 
 
19 (47.5%) 
 
12 (30 %) 
 
8 (20%) 
 
1 (2.5%) 
 
 
 
 
30 (75%) 
 
9 (22.5%) 
 
1 (2.5%) 
 
-  
 
 
 
 
0.013* 
 
 
Cormack lehanne grading: 
                              There was no significant difference in the grading of 
intubation between the 2 groups. The data is shown in table 4. 
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Table 4: Cormack lehanne grading 
 
 
 PROPOFOL SEVOFLURANE P VALUE 
C/L grade 
 
1 
 
2 
 
3 
 
 
27 
 
11 
 
2 
 
 
30 
 
10 
 
  - 
 
 
0.458 
 
Apnea: 
             There was apnea in 100 % of patients in group P and 12.5% of 
patients in group S (P – 0.0001).  
 
Table 5: Incidence of apnea 
 
 PROPOFOL SEVOFLURANE P VALUE 
APNEA  
 
YES 
 
 
NO 
 
 
40(100%) 
 
 
 - 
 
 
5(12.5%) 
 
 
35(87.5%) 
 
 
< 0.0001* 
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Hemodynamic parameters: 
 
 There was no significant difference in the heart rate and systolic blood 
pressure before, following induction, immediately after intubation, 1 
min and 5 minutes after intubation between the 2 groups.   
 
 Diastolic blood pressure decreased significantly 1 min and 5 min after 
intubation between the 2 groups which is shown in table 6.  
 
 Mean arterial pressure decreased significantly 1 minute and 5 minute 
after intubation compared with the baseline.  
 
 
 MAP 1 min after intubation was 78.08   10.03 mm Hg in group P and  
82.82   10.05 mm Hg in group S. MAP 5 minutes after intubation 
was 79.95   11.08 mm Hg in group P and 84.42   9.61 mm Hg in 
group S. The data are shown in table 7.  
 
 Although there was reduction in MAP, the mean arterial pressure in 
both the groups were well maintained above 70 mm Hg. None of the 
patients required ephedrine or atropine in our study.  
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Table 6: Heart rate, systolic and diastolic blood pressure 
 
 
 Propofol (group P) Sevoflurane (group S) 
HEART RATE 
 
Baseline 
 
After induction 
 
After intubation 
 
1 min after intubation 
 
5 min after intubation 
 
 
90.42   18.44 
 
87.75   16.20 
 
92.28   17.61 
 
89.95   14.66 
 
87.78   12.32 
 
 
91.42   13.21 
 
87.40   16.35 
 
91.45   17.59 
 
88.15   15.03 
 
84.70   14.48 
SYSTOLIC BP 
 
Baseline 
 
After induction 
 
After intubation 
 
1 min after intubation 
 
5 min after intubation 
 
 
119.35   13.94 
 
98.5   11.48 
 
105.58   17.60 
 
101.28   12.88 
 
101.12   13.77 
 
 
122.78   15.37 
 
98.2   13.10 
 
103.85   17.09 
 
103.65   14.20 
 
106.32   12.11 
DIASTOLIC BP 
 
Baseline 
 
After induction 
 
After intubation 
 
1 min after intubation 
 
5 min after intubation 
 
 
 
 
78.92   9.05 
 
67.28   9.66 
 
70.75   11.19 
 
66.90   9.71 
 
69.18   10.67 
 
 
81.42   8.57 
 
67.18   10.44 
 
71.75   13.90 
 
73   9.08* 
 
74.75   9.36* 
Values expressed as mean      *P <0.05 
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Table 7 : Mean arterial pressure 
 
 
Mean arterial pressure 
 
Baseline 
 
After induction 
 
After intubation 
 
1 min after intubation 
 
5 min after intubation 
 
 
92.10   9.85 
 
77.55   9.54 
 
82.28   12.28 
 
78.08   10.03 
 
79.95   11.08 
 
 
95.12   10.40 
 
77.55   10.75 
 
82.02   14.15 
 
82.82   10.05* 
 
84.42   9.61* 
Values expressed as mean      *P <0.05 
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DISCUSSION 
 
                           Our data showed that trachea can be reliably 
intubated without muscle relaxant with sevoflurane induction and 
intravenous fentanyl in premedicated healthy adult patients with 
favorable airway. In our study, patients who received sevoflurane 
induction and fentanyl 2 µg/kg had better intubating conditions than 
propofol 3 mg/kg and fentanyl 2 µg/kg. The success ratio of 
acceptable (optimal to good) intubating conditions was 100 % in 
sevoflurane group and 82.5 % in propofol group.   
                          Iamaroon and colleagues compared thiopental and 
succinylcholine versus sevoflurane 8% with nitrous oxide (N20) 66%. 
The succinylcholine group achieved excellent or good intubating 
conditions in almost 100 % patients whereas the sevoflurane group 
with vital capacity induction also achieved the same success rate 
compared with succinylcholine group.
11
 Our results were similar to 
the results achieved by the sevoflurane group in this study.  
 
                         Muzi et al. reported that the mean time (95 % CI) for 
successful tracheal intubating conditions in sevoflurane induction with 
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66 % nitrous oxide was 4.7 (3.7-5.7 min) and without nitrous oxide 
was 6.4 (5.1-7.7 min). In our study, we had optimal to good intubating 
conditions in sevoflurane induction because we used 5 min time 
interval for induction to intubation which was similar to the results of 
Muzi et al. The difference is that we used stepwise incremental 
induction in our study whereas muzi and colleagues used Dixon’s up 
and down technique for induction.
12
  
                           Bonnin et al. studied 52 patients comparing 
sevoflurane and target controlled propofol infusion for difficult airway 
with fiberoptic bronchoscope. They concluded that sevoflurane with 
tidal volume ventilation provided better fiberoptic intubating 
conditions than propofol. The results related to the intubating 
conditions and the apneic episodes were almost identical to our 
study.
13 
                          Joo et al. studied 56 female patients and reported that 
remifentanil sevoflurane combination produces excellent intubating 
conditions which was around 90 % without muscle relaxants in adults. 
The results of this study resembled our study where the optimal 
intubating conditions was 92.5 %.
14 
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                       Kimura et al. determined that the MAC- EI 
(endotracheal intubation) of sevoflurane was 4.52% and the ED95 
needed for tracheal intubation was 8.07%.
15
 We used 8 % 
concentration for sevoflurane induction in our study which is 
supported by the above study.  
                           Batra et al. demonstrated that propofol 3 mg/kg 
combined with remifentanil 3 µg/kg provided optimal intubating 
conditions in children.
16
  
                          Andel et al. studied the propofol requirement for 
laryngoscopic tracheal intubation and fiberoptic intubation. They 
found that the median requirement for conventional laryngoscopic 
tracheal intubation was 2.74 ± 1.59 mg/kg  and fiberoptic intubation 
was 1.37 ± 0.59 mg/kg.
17
 In our study, we used propofol at a dose of 3 
mg/kg which is supported by these studies.                              
                              Batra et al. achieved acceptable intubating 
conditions in 18 out of 20 children (90% ) using propofol 3 mg/kg and 
remifentanil 3 µg/kg.
16
  
                             Andel et al. determined the requirement of the dose 
of propofol for tracheal intubation by laryngoscopy and fiberoptic 
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bronchoscopy and he found that jaw relaxation was optimal in 93.75 
% of patients.
17
  
                            Grant et al. assessed the intubating conditions in 60 
patients who received propofol 2 mg/kg and remifentanil 2 µg/kg and 
they achieved acceptable intubating conditions in 80% of patients.
18  
                           Coghlan et al. investigated propofol 2.5 mg/kg and 
alfentanil 20 µg/kg and achieved successful intubation in 83% of 
patients.
19
  
                           Robert et al. reported that the equipotent dose of 
fentanyl and alfentanil was 10 µg/kg and 75 µg/kg.
20
 In our study,if 
the fentanyl dose of 2 µg/kg is compared with the equipotent dose of 
alfentanil 20 µg/kg in coghlan et al., propofol and fentanyl would be 
comparable in terms of intubating conditions. The success ratio of the 
intubating conditions in the propofol group in our study was 82.5%, 
the results of which were comparable to the previous studies.  
                            The most effective time of injection of fentanyl to 
attenuate the hemodynamic response to laryngoscopy and intubation 
had been found to be 5 minutes after its administration because of its 
peak effect.
21
 Hence we administered fentanyl 5  minutes before 
induction.  
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                           Laubie et al. demonstrated that the action of fentanyl 
is on the solitary nuclei and the nuclei of glossopharyngeal and vagus 
nerves.
22
  
                          Muzi et al. suggested that the time of induction was 
significantly shorter in patients who were premedicated with fentanyl 
or midazolam before induction and they found that fentanyl or 
midazolam administered intravenously 5 minutes before induction 
shortened the time to achieve optimal intubating conditions in 
adults.
23 
                           Intravenous lignocaine has been shown to suppress 
cough reflex.
24
 Yukioka et al. reported that intravenous lignocaine 
used at a dose of 2 mg/kg suppressed cough significantly when given 
1 minute before intubation.
25
 Several studies showed that there was no 
significant improvement in the intubating conditions when used alone 
with induction agent.
26 27
 We used intravenous lignocaine in addition 
to fentanyl in our study due to these reasons.  
                          Pancaro et al. studied 131 women who received 
incremental concentration or decremental-incremental or fixed 
concentration of  8%  sevoflurane for induction of anesthesia. They 
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observed that apnea was frequent in the fixed concentration group 
than the incremental induction group (68 % vs 21%). They concluded 
that apnea occurred more frequently in the high concentration group 
than the incremental induction group.
28
 In our study, incremental 
induction of sevoflurane was done and incidence of apnea was 12.5 % 
which was almost similar to the previous study. 
                        Pean et al. compared sevoflurane and propofol for 
difficult airway and reported that coughing was present in 74% of 
patients in propofol group and 54% of patients in sevoflurane group.
9
 
  
                        D.Karaaslan et al. compared sevoflurane and propofol 
with remifentanil for tracheal intubation without neuromuscular 
blocking agents and reported coughing after intubation and cuff 
inflation in 40% of patients in sevoflurane group and 5% and 10% in 
propofol group.
29
  
                          Scheller et al. compared propofol 2 mg/kg with 
various doses of alfentanil and reported 16 out of 60 patients(26%) 
who coughed once or twice after intubation or cuff inflation and 5 out 
of 15 (33%) patients in 30 µg/kg alfentanil group necessitated 
succinylcholine for intubation because of unacceptable intubating 
conditions.
30
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                        Taha et al. compared the intubating conditions of 
propofol and thiopentone and reported that coughing was present in 
8% of patients in propofol group.
31
  
                       Iamaroon et al. reported that mild or moderate 
coughing were present in 21% of patients belonging to sevoflurane 
group.
11
  
                          Khoury et al. compared propofol with fentanyl versus 
alfentanil and reported that coughing after intubation in the fentanyl 
group were present in 15 out of 40 patients (37.5%).
32
  
                        
                      In our study, marginal or poor intubating conditions 
were present in 7 out of 40 (17.5%) patients of propofol group 
whereas it was nil in sevoflurane group. Mild or moderate coughing 
were present in 35% of patients in propofol group and 10% of patients 
in sevoflurane group. 1 patient in the propofol group had severe 
coughing and closed glottis which required succinylcholine for 
tracheal intubation. 
                      We observed a significant fall in the mean and the 
diastolic blood pressure 1 and 5 minutes after intubation. The drop in 
diastolic blood pressure 1 min and 5 min after intubation was down to 
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66.90   9.71 ; 69.18   10.67 mm Hg in propofol group and 73   9.08 
; 74.75   9.36 mm Hg in sevoflurane group.  
 
                            The drop in mean arterial pressure 1 min and 5 min 
after intubation was down to 78.08   10.03 ; 79.95   11.08 mm Hg in 
propofol group and 82.82   10.05 ; 84.42   9.61 mm Hg in 
sevoflurane group. But the mean arterial pressure was well above 70 
mm Hg in all the patients of both the groups. The heart rate and 
systolic blood pressure in both the groups didn’t show any significant 
changes compared to baseline.  
 
 
 
 
 
 
 
 
 
 
 
 75 
 
SUMMARY 
 
Comparing the effectiveness of sevoflurane and propofol with fentanyl for 
tracheal intubation without muscle Relaxant in our study we summarize: 
 
 Optimal intubating conditions were better in sevoflurane – fentanyl 
(92.5%) combination than propofol – fentanyl (52.5%) 
combination.(P – 0.0001). 
 
 Acceptable (optimal or good) intubating conditions was best with 
sevoflurane – fentanyl (100%) combination than propofol – fentanyl 
(82.5%) combination. (P – 0.011). 
 
 
 Cough after intubation and cuff inflation was least in sevoflurane 
group than in propofol group. (90% vs 62.5%) – P = 0.026 ; (97.5% 
vs 77.5%) – P = 0.013. 
 
 Apnea was more pronounced with propofol group (100%) than with 
sevoflurane group (12.5%) (P – 0.0001). 
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 There was significant reduction in the mean arterial pressure 1 min 
and 5 minutes after intubation compared with baseline but the mean 
arterial pressure was well maintained above 70 mm Hg.  
 
 There was no difference in the heart rate,systolic and diastolic blood 
pressure between the 2 groups. 
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CONCLUSION 
 
                           In conclusion, anaesthetic induction and tracheal intubation 
without muscle relaxants in premedicated healthy adult patients undergoing 
elective surgery is better achieved by incremental induction of sevoflurane 
and fentanyl 2 µg/kg than with propofol 3 mg/kg and fentanyl 2 µg/kg. The 
intubating conditions were better with sevoflurane – fentanyl – lidocaine 
combination than propofol –fentanyl - lidocaine. Hemodynamic changes 
were similar in both the groups. 
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INFORMATION TO PARTICIPANTS 
 
Investigator                     :Dr.PremKumar.M 
 
Name of the Participant: 
 
Title                   :       Comparison of sevoflurane and propofol with fentanyl for tracheal   
                                 Intubation without muscle relaxant  
 
You are invited to take part in this research study. We have got approval from the IEC. You are 
asked to participate because you satisfy the eligibility criteria .We want to compare the 
effectiveness of propofol and  Sevoflurane with fentanyl for tracheal intubation without muscle 
Relaxant. 
What is the Purpose of the Research: 
This study has been done to compare the effectiveness of propofoland  Sevoflurane with 
fentanyl for tracheal intubation without muscle Relaxant in elective abdominal surgeries. Muscle 
relaxants usage in general anesthesia can cause prolonged duration and postoperative residual 
paralysis which may cause respiratory difficulty and further complications in certain conditions 
like hyperkalemia,cholinesterasedeficiency,burns,penetrating eye injury, myopathies,allergic 
reactions. This study will be of use in short duration surgeries where muscle relaxant is not 
needed and difficult airway situations where muscle relaxants are undesirable. 
The Study Design: 
                          This study has been done to compare the effectiveness of propofol and  
Sevoflurane with fentanyl for tracheal intubation without muscle Relaxant in elective abdominal 
surgeries. Muscle relaxants usage in general anesthesia can cause postoperative residual 
paralysis which may cause respiratory difficulty and is contraindicated in certain conditions. This 
study will be of use in those conditions and in short duration surgeries where muscle relaxant is 
not needed and difficult airway situations where muscle relaxants are undesirable. 
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Benefits: 
 With propofol and sevoflurane, there would be better intubating conditions without 
muscle relaxants and it would be useful in short duration surgeries. It would be useful in difficult 
airway also because of maintenance of spontaneous ventilation.  
Discomforts and risks: 
                    Reduction in heart rate and blood pressure can occur.coughing during intubation can 
occur.If heart rate reduces then we give inj.Atropine or if blood pressure reduces we give 
inj.ephedrine. if there is severe coughing during intubation, intubation would be facilitated by 
muscle relaxant. There is risk of cannot ventilate and cannot intubate situation which can occur 
in 0.1% of population where emergency airway may be placed like laryngeal mask airway, 
tracheostomy or cricothyroidotomy 
This intervention has been shown to be well tolerated as shown by previous studies. And if you 
do not want to participate you will have alternative of setting the standard treatment and your 
safety is our prime concern. 
 
Time : 
Date : 
Place : 
Signature / Thumb Impression of 
Patient 
Patient Name: 
Signature of the Investigator : ____________________________ 
Name of the Investigator : ____________________________ 
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PATIENT CONSENT FORM 
Study title        :         Comparison of sevoflurane and propofol with fentanyl for   
                               Tracheal intubation without muscle relaxant  
 
 
Study centre    :           Department of Anaesthesiology 
 Institute of Anesthesiology and critical care, 
                                       Madras Medical College 
                                       Chennai 600003  
           
 
Participant name :                                                Age:                         Sex:                                I.P.No: 
 
 
                        I confirm that i have understood the purpose of procedure for the above study .i 
had the opportunity to ask questions and all my questions and doubts have been answered to 
my satisfaction. 
 
                        I have been explained about the pitfall in the procedure.  I have been explained 
about the safety, advantage and disadvantage of the technique. 
 
                        I understand that my participation in the study is voluntary and that i am free to 
withdraw at anytime without giving any reason. 
 
                        I understand that the investigator ,regulatory authorities and the ethical 
committee will not need my permission to look at my health records both in respect to current 
study and any further research that may be conducted in relation to it, even if i withdraw from 
the study . I understand that my identity will not be revealed in any information released to 
third parties or published , unless as required under the law . I agree not to restrict the use of 
any data or results that arise from the study . 
 
Time:          
 
Date:                                                                                            signature / thumb impression of patient  
 
Place:                                                                                            patient name: 
 
Signature of the investigator: 
 
Name of the investigator: 
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PROFORMA 
 
 
NAME:                                                 AGE:             SEX:                       I.P. NO. 
 
DIAGNOSIS:                                                                WT:                    MMS CLASS:   
 
SURGERY PERFORMED:                                              GROUP: 
 
 
 
1. HEMODYNAMICS: 
 
      
    HR 
 
        BP 
     
     MAP 
BASELINE    
AFTER INDUCTION    
AFTER INTUBATION    
1 MIN AFTER INTUBATION    
5 MIN AFTER INTUBATION    
 
 
2. INTUBATING CONDITIONS: 
 
 OPTIMAL   GOOD  POOR INADEQUATE 
JAW RELAXATION     
VOCAL CORD 
POSITION 
    
LIMB MOVEMENT     
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3. COUGHING AFTER INTUBATION 
 
    
     NONE        MILD            MODERATE    SEVERE 
    
      
 
 
4. COUGHING AFTER CUFF INFLATION 
 
    
     NONE        MILD            MODERATE    SEVERE 
    
      
  
5. C/L GRADE -                                 
 
 
6. Apnea during induction – yes/no  
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HEART RATE :  
 
 
NAME AGE SEX WEIGHT HEIGHT GROUP HR BASELINE AFTER 
IND 
AFTER 
INT 
1 MIN 5 MIN 
murugan  40 male 60 158 propofol  80 68 85 74 72 
sathya 32 female 60 155 propofol  102 96 98 91 94 
vijayalakshmi 26 female 55 156 propofol  93 86 102 96 88 
sriram 60 male 65 160 propofol  85 88 72 84 86 
krishnan 55 male 70 162 propofol  58 56 80 69 67 
poongodi 31 female 65 152 propofol  97 86 74 93 90 
mangai 48 female 60 155 propofol  78 80 92 80 82 
saranya 20 female 45 145 propofol  93 90 95 118 86 
anbalagan 16 male 50 150 propofol  102 85 108 105 109 
sivagami 23 female 60 157 propofol  92 94 88 78 82 
manikandan 17 male 50 154 propofol  98 81 85 68 70 
nivedini 15 female 35 150 propofol  102 96 99 102 97 
palani 23 male 60 165 propofol  94 92 97 94 95 
kalaivannan 28 male 67 162 propofol  104 102 100 102 102 
datchinamoorthy 52 male 58 166 propofol  85 95 70 88 78 
chitra 45 female 70 157 propofol  68 74 71 68 76 
ilayaraja 26 male 63 164 propofol  71 84 91 86 88 
manjula 32 female 63 158 propofol  64 62 90 103 94 
prabu 19 male 55 154 propofol  124 107 94 95 92 
nagaraj 18 male 60 152 propofol  84 103 124 94 86 
rachel 29 female 50 157 propofol  115 130 118 103 90 
murugan  46 male 70 166 propofol  103 93 88 104 92 
shanthi 23 female 40 160 propofol  135 118 121 112 102 
anwar basha 35 male 70 168 propofol  97 85 103 95 70 
loganayagi 31 female 60 155 propofol  70 74 71 72 74 
backiyam 40 female 55 157 propofol  79 80 85 88 90 
vishnupriya 15 female 35 145 propofol  102 88 90 96 101 
valliammal 50 female 55 151 propofol  104 93 88 76 103 
saraswathi 27 female 50 155 propofol  69 76 78 82 86 
andaal 35 female 70 153 propofol  77 78 86 66 68 
seenu kumar 30 male 45 158 propofol  118 122 130 119 112 
mala 32 female 70 161 propofol  67 68 72 70 75 
kala  36 female 50 155 propofol  90 84 102 92 102 
sridhar 42 male 60 170 propofol  90 88 107 105 87 
lavanya 18 female 40 155 propofol  110 98 120 103 96 
suman 24 male 65 168 propofol  47 53 47 61 57 
palkish 44 female 60 153 propofol  99 95 94 92 94 
mani  55 male 60 167 propofol  107 102 120 104 98 
meena 15 female 50 154 propofol  88 92 84 90 96 
selvadoss 35 male 54 162 propofol  76 68 72 80 84 
rosy 24 female 50 155 sevoflurane  98 104 113 105 100 
dhanam 33 female 60 158 sevoflurane  92 98 106 100 98 
desammal 40 female 40 162 sevoflurane  84 88 84 86 84 
prema 45 female 55 155 sevoflurane  66 60 72 68 60 
poongodi 35 female 60 157 sevoflurane  104 98 108 94 92 
kamalakannan 24 male 60 165 sevoflurane  90 76 78 76 71 
subashini 25 female 50 155 sevoflurane  108 94 104 103 102 
anju 25 female 65 161 sevoflurane  101 90 87 93 92 
kannagi 45 female 65 150 sevoflurane  92 68 64 72 68 
sathyapriya 22 female 40 147 sevoflurane  106 100 104 92 90 
kadhar basha 36 male 60 166 sevoflurane  85 82 85 78 76 
hema kumar 24 male 70 173 sevoflurane  79 82 84 85 72 
sabapathy 40 male 60 163 sevoflurane  103 108 111 108 106 
shankari 30 female 70 154 sevoflurane  86 75 80 82 80 
velu 48 male 65 161 sevoflurane  96 75 73 76 74 
anbu 42 male 65 168 sevoflurane  98 72 81 91 73 
parvathi 25 female 40 156 sevoflurane  85 80 95 96 99 
nandhini 19 female 50 156 sevoflurane  121 128 124 118 114 
ramya 15 female 50 158 sevoflurane  86 85 90 78 82 
balan 30 male 60 166 sevoflurane  76 94 83 86 88 
kuppan 60 male 60 162 sevoflurane  80 85 90 98 82 
vijayan 58 male 65 159 sevoflurane  78 82 110 92 88 
jerome 23 male 60 163 sevoflurane  86 92 90 96 92 
deepan 28 male 55 158 sevoflurane  102 98 94 91 90 
uma 30 female 60 159 sevoflurane  97 92 90 86 76 
ramani 28 female 70 151 sevoflurane  82 76 82 76 74 
dharmaraj 58 male 75 161 sevoflurane  65 56 52 51 55 
shanthi 42 female 60 155 sevoflurane  91 78 100 84 82 
kalaivani 25 female 50 158 sevoflurane  80 98 100 84 81 
ramzan 35 male 65 175 sevoflurane  95 58 54 56 58 
amarvalli 45 female 60 154 sevoflurane  70 64 74 70 72 
mymuna 35 female 55 150 sevoflurane  101 98 92 94 92 
sangeetha 30 female 50 157 sevoflurane  95 101 110 103 93 
hariprasath 16 male 50 161 sevoflurane  110 126 132 122 118 
gopi 27 male 60 166 sevoflurane  82 82 76 66 64 
karthik 17 male 50 151 sevoflurane  94 88 106 98 88 
thilagavathy 38 female 60 154 sevoflurane  117 86 94 90 92 
martha david 50 female 80 157 sevoflurane  110 112 112 104 102 
jaya 34 female 55 158 sevoflurane  74 71 72 80 76 
rajam 30 female 50 155 sevoflurane  92 96 102 98 92 
 
 
SYSTOLIC BLOOD PRESSURE:  
 
 
 
NAME AGE SEX WEIGHT HEIGHT GROUP 
SYS BP BASELINE 
AFTER 
IND 
AFTER 
INT 1 MIN 5 MIN 
murugan  40 male 60 158 propofol  123 84 91 91 90 
sathya 32 female 60 155 propofol  110 90 96 94 100 
vijayalakshmi 26 female 55 156 propofol  120 100 104 110 108 
sriram 60 male 65 160 propofol  163 140 149 126 106 
krishnan 55 male 70 162 propofol  130 97 130 90 100 
poongodi 31 female 65 152 propofol  124 103 91 91 96 
mangai 48 female 60 155 propofol  110 80 90 100 120 
saranya 20 female 45 145 propofol  110 110 100 100 110 
anbalagan 16 male 50 150 propofol  100 100 120 120 126 
sivagami 23 female 60 157 propofol  129 108 101 97 99 
manikandan 17 male 50 154 propofol  118 100 108 108 100 
nivedini 15 female 35 150 propofol  100 80 80 85 70 
palani 23 male 60 165 propofol  120 100 110 124 100 
kalaivannan 28 male 67 162 propofol  140 118 129 109 109 
datchinamoorthy 52 male 58 166 propofol  130 90 150 80 80 
chitra 45 female 70 157 propofol  116 88 103 86 85 
ilayaraja 26 male 63 164 propofol  135 101 110 90 102 
manjula 32 female 63 158 propofol  100 98 80 90 100 
prabu 19 male 55 154 propofol  120 90 100 94 80 
nagaraj 18 male 60 152 propofol  130 100 110 100 100 
rachel 29 female 50 157 propofol  120 90 126 110 100 
murugan  46 male 70 166 propofol  136 81 73 93 110 
shanthi 23 female 40 160 propofol  110 90 92 100 100 
anwar basha 35 male 70 168 propofol  103 94 107 104 89 
loganayagi 31 female 60 155 propofol  134 113 119 118 98 
backiyam 40 female 55 157 propofol  110 100 110 98 90 
vishnupriya 15 female 35 145 propofol  130 100 119 100 110 
valliammal 50 female 55 151 propofol  141 115 124 90 64 
saraswathi 27 female 50 155 propofol  112 110 95 95 97 
andaal 35 female 70 153 propofol  95 90 101 90 121 
seenu kumar 30 male 45 158 propofol  122 98 94 111 109 
mala 32 female 70 161 propofol  130 100 110 110 120 
kala  36 female 50 155 propofol  110 100 120 130 110 
sridhar 42 male 60 170 propofol  110 100 110 100 90 
lavanya 18 female 40 155 propofol  106 85 79 80 97 
suman 24 male 65 168 propofol  124 99 97 101 100 
palkish 44 female 60 153 propofol  120 110 100 98 110 
mani  55 male 60 167 propofol  100 98 121 111 109 
meena 15 female 50 154 propofol  110 100 90 130 110 
selvadoss 35 male 54 162 propofol  123 90 84 97 130 
rosy 24 female 50 155 sevoflurane  104 99 112 104 100 
dhanam 33 female 60 158 sevoflurane  127 100 127 124 124 
desammal 40 female 40 162 sevoflurane  120 100 110 108 110 
prema 45 female 55 155 sevoflurane  100 90 104 99 100 
poongodi 35 female 60 157 sevoflurane  112 96 106 100 110 
kamalakannan 24 male 60 165 sevoflurane  150 119 106 101 99 
subashini 25 female 50 155 sevoflurane  134 93 108 109 124 
anju 25 female 65 161 sevoflurane  117 108 119 132 135 
kannagi 45 female 65 150 sevoflurane  130 110 90 94 100 
sathyapriya 22 female 40 147 sevoflurane  122 88 84 101 110 
kadhar basha 36 male 60 166 sevoflurane  133 114 127 117 113 
hema kumar 24 male 70 173 sevoflurane  90 80 80 80 90 
sabapathy 40 male 60 163 sevoflurane  100 90 100 90 92 
shankari 30 female 70 154 sevoflurane  110 90 90 100 108 
velu 48 male 65 161 sevoflurane  110 90 94 90 100 
anbu 42 male 65 168 sevoflurane  129 97 111 93 88 
parvathi 25 female 40 156 sevoflurane  106 87 86 92 109 
nandhini 19 female 50 156 sevoflurane  132 106 128 127 121 
ramya 15 female 50 158 sevoflurane  115 70 82 119 117 
balan 30 male 60 166 sevoflurane  109 88 77 88 94 
kuppan 60 male 60 162 sevoflurane  120 100 90 100 110 
vijayan 58 male 65 159 sevoflurane  130 96 139 107 110 
jerome 23 male 60 163 sevoflurane  100 96 117 115 119 
deepan 28 male 55 158 sevoflurane  97 80 95 96 115 
uma 30 female 60 159 sevoflurane  121 117 115 113 112 
ramani 28 female 70 151 sevoflurane  130 110 90 100 108 
dharmaraj 58 male 75 161 sevoflurane  130 110 100 90 110 
shanthi 42 female 60 155 sevoflurane  142 135 149 136 133 
kalaivani 25 female 50 158 sevoflurane  114 97 116 113 107 
ramzan 35 male 65 175 sevoflurane  132 99 88 89 90 
amarvalli 45 female 60 154 sevoflurane  166 92 84 91 91 
mymuna 35 female 55 150 sevoflurane  130 110 100 92 100 
sangeetha 30 female 50 157 sevoflurane  144 97 110 142 124 
hariprasath 16 male 50 161 sevoflurane  125 85 94 91 100 
gopi 27 male 60 166 sevoflurane  130 90 100 102 94 
karthik 17 male 50 151 sevoflurane  130 110 120 100 90 
thilagavathy 38 female 60 154 sevoflurane  130 70 110 104 90 
martha david 50 female 80 157 sevoflurane  130 110 120 110 106 
jaya 34 female 55 158 sevoflurane  130 109 76 97 100 
rajam 30 female 50 155 sevoflurane  130 100 100 90 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIASTOLIC BLOOD PRESSURE: 
 
 
 
 
NAME AGE SEX WEIGHT HEIGHT GROUP 
DIAS BP BASELINE 
AFTER 
IND 
AFTER 
INT 1 MIN 5 MIN 
murugan  40 male 60 158 propofol  84 59 60 60 58 
sathya 32 female 60 155 propofol  70 60 72 62 70 
vijayalakshmi 26 female 55 156 propofol  70 80 80 70 60 
sriram 60 male 65 160 propofol  93 98 103 89 77 
krishnan 55 male 70 162 propofol  90 60 90 70 72 
poongodi 31 female 65 152 propofol  84 60 56 56 66 
mangai 48 female 60 155 propofol  80 60 60 70 80 
saranya 20 female 45 145 propofol  80 80 70 80 80 
anbalagan 16 male 50 150 propofol  80 80 84 80 82 
sivagami 23 female 60 157 propofol  87 72 60 58 62 
manikandan 17 male 50 154 propofol  70 66 78 70 80 
nivedini 15 female 35 150 propofol  80 60 60 62 50 
palani 23 male 60 165 propofol  70 60 70 65 62 
kalaivannan 28 male 67 162 propofol  90 92 82 59 89 
datchinamoorthy 52 male 58 166 propofol  80 70 80 60 60 
chitra 45 female 70 157 propofol  78 59 71 58 60 
ilayaraja 26 male 63 164 propofol  98 71 70 60 74 
manjula 32 female 63 158 propofol  70 66 62 64 68 
prabu 19 male 55 154 propofol  70 60 62 60 62 
nagaraj 18 male 60 152 propofol  90 70 80 70 62 
rachel 29 female 50 157 propofol  70 70 80 60 70 
murugan  46 male 70 166 propofol  103 58 55 71 70 
shanthi 23 female 40 160 propofol  70 70 64 60 72 
anwar basha 35 male 70 168 propofol  69 59 73 72 58 
loganayagi 31 female 60 155 propofol  88 66 79 59 57 
backiyam 40 female 55 157 propofol  70 66 70 60 70 
vishnupriya 15 female 35 145 propofol  80 72 80 76 72 
valliammal 50 female 55 151 propofol  77 66 74 63 46 
saraswathi 27 female 50 155 propofol  70 69 64 65 65 
andaal 35 female 70 153 propofol  68 65 71 64 92 
seenu kumar 30 male 45 158 propofol  82 65 68 73 71 
mala 32 female 70 161 propofol  90 80 70 80 76 
kala  36 female 50 155 propofol  80 62 72 98 78 
sridhar 42 male 60 170 propofol  70 62 82 70 60 
lavanya 18 female 40 155 propofol  75 56 51 48 67 
suman 24 male 65 168 propofol  75 56 54 52 56 
palkish 44 female 60 153 propofol  72 82 72 70 68 
mani  55 male 60 167 propofol  68 60 86 74 69 
meena 15 female 50 154 propofol  80 66 62 72 86 
selvadoss 35 male 54 162 propofol  86 58 53 66 90 
rosy 24 female 50 155 sevoflurane  78 72 80 76 70 
dhanam 33 female 60 158 sevoflurane  86 65 91 83 82 
desammal 40 female 40 162 sevoflurane  70 62 72 66 70 
prema 45 female 55 155 sevoflurane  68 62 68 72 80 
poongodi 35 female 60 157 sevoflurane  76 68 72 76 80 
kamalakannan 24 male 60 165 sevoflurane  92 49 64 60 63 
subashini 25 female 50 155 sevoflurane  89 57 74 73 91 
anju 25 female 65 161 sevoflurane  72 72 72 97 98 
kannagi 45 female 65 150 sevoflurane  90 80 70 72 70 
sathyapriya 22 female 40 147 sevoflurane  76 51 50 59 80 
kadhar basha 36 male 60 166 sevoflurane  85 75 82 71 70 
hema kumar 24 male 70 173 sevoflurane  70 60 60 60 70 
sabapathy 40 male 60 163 sevoflurane  70 70 72 70 60 
shankari 30 female 70 154 sevoflurane  80 70 72 72 66 
velu 48 male 65 161 sevoflurane  74 72 60 72 80 
anbu 42 male 65 168 sevoflurane  90 71 75 66 66 
parvathi 25 female 40 156 sevoflurane  66 52 53 65 88 
nandhini 19 female 50 156 sevoflurane  88 72 88 87 83 
ramya 15 female 50 158 sevoflurane  72 42 48 83 81 
balan 30 male 60 166 sevoflurane  73 59 51 59 60 
kuppan 60 male 60 162 sevoflurane  86 70 62 70 84 
vijayan 58 male 65 159 sevoflurane  94 73 117 70 68 
jerome 23 male 60 163 sevoflurane  70 70 83 83 85 
deepan 28 male 55 158 sevoflurane  73 57 72 71 86 
uma 30 female 60 159 sevoflurane  77 80 77 70 77 
ramani 28 female 70 151 sevoflurane  92 74 76 76 72 
dharmaraj 58 male 75 161 sevoflurane  80 74 84 66 72 
shanthi 42 female 60 155 sevoflurane  94 92 103 91 90 
kalaivani 25 female 50 158 sevoflurane  80 67 81 79 76 
ramzan 35 male 65 175 sevoflurane  86 72 68 68 70 
amarvalli 45 female 60 154 sevoflurane  99 58 55 64 65 
mymuna 35 female 55 150 sevoflurane  92 80 68 70 70 
sangeetha 30 female 50 157 sevoflurane  89 60 76 95 81 
hariprasath 16 male 50 161 sevoflurane  83 54 73 71 70 
gopi 27 male 60 166 sevoflurane  80 66 72 78 60 
karthik 17 male 50 151 sevoflurane  80 72 66 70 64 
thilagavathy 38 female 60 154 sevoflurane  80 54 70 70 70 
martha david 50 female 80 157 sevoflurane  90 86 81 82 84 
jaya 34 female 55 158 sevoflurane  87 71 50 67 68 
rajam 30 female 50 155 sevoflurane  80 76 62 70 70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MEAN ARTERIAL PRESSURE: 
 
 
 
NAME AGE SEX WEIGHT HEIGHT GROUP 
MAP BASELINE 
AFTER 
IND 
AFTER 
INT 1 MIN 5 MIN 
murugan  40 male 60 158 propofol  97 67 70 70 69 
sathya 32 female 60 155 propofol  83 70 80 73 80 
vijayalakshmi 26 female 55 156 propofol  87 86 88 83 76 
sriram 60 male 65 160 propofol  116 112 118 101 87 
krishnan 55 male 70 162 propofol  103 72 103 76 81 
poongodi 31 female 65 152 propofol  97 74 68 68 76 
mangai 48 female 60 155 propofol  90 66 70 80 93 
saranya 20 female 45 145 propofol  90 90 80 86 90 
anbalagan 16 male 50 150 propofol  86 86 96 93 97 
sivagami 23 female 60 157 propofol  101 84 74 71 74 
manikandan 17 male 50 154 propofol  86 77 88 83 86 
nivedini 15 female 35 150 propofol  86 67 67 70 57 
palani 23 male 60 165 propofol  87 73 83 85 75 
kalaivannan 28 male 67 162 propofol  107 101 98 76 96 
datchinamoorthy 52 male 58 166 propofol  97 76 103 67 67 
chitra 45 female 70 157 propofol  91 69 82 57 68 
ilayaraja 26 male 63 164 propofol  110 81 83 70 83 
manjula 32 female 63 158 propofol  80 76 68 73 78 
prabu 19 male 55 154 propofol  87 70 75 71 68 
nagaraj 18 male 60 152 propofol  103 80 90 80 75 
rachel 29 female 50 157 propofol  87 76 95 77 80 
murugan  46 male 70 166 propofol  114 66 61 78 83 
shanthi 23 female 40 160 propofol  83 76 73 73 81 
anwar basha 35 male 70 168 propofol  80 71 84 83 68 
loganayagi 31 female 60 155 propofol  103 82 92 79 71 
backiyam 40 female 55 157 propofol  83 77 83 73 76 
vishnupriya 15 female 35 145 propofol  96 81 93 84 84 
valliammal 50 female 55 151 propofol  98 82 91 72 52 
saraswathi 27 female 50 155 propofol  84 83 74 75 76 
andaal 35 female 70 153 propofol  77 73 81 73 102 
seenu kumar 30 male 45 158 propofol  95 78 77 86 84 
mala 32 female 70 161 propofol  103 86 83 90 90 
kala  36 female 50 155 propofol  83 74 88 108 88 
sridhar 42 male 60 170 propofol  83 74 91 80 70 
lavanya 18 female 40 155 propofol  85 66 60 59 77 
suman 24 male 65 168 propofol  91 70 68 68 71 
palkish 44 female 60 153 propofol  88 91 81 79 82 
mani  55 male 60 167 propofol  79 73 98 86 82 
meena 15 female 50 154 propofol  90 77 71 91 94 
selvadoss 35 male 54 162 propofol  98 69 63 76 103 
rosy 24 female 50 155 sevoflurane  87 81 91 85 80 
dhanam 33 female 60 158 sevoflurane  100 77 103 97 96 
desammal 40 female 40 162 sevoflurane  87 75 85 80 83 
prema 45 female 55 155 sevoflurane  78 71 80 81 86 
poongodi 35 female 60 157 sevoflurane  88 77 83 84 90 
kamalakannan 24 male 60 165 sevoflurane  111 72 78 74 75 
subashini 25 female 50 155 sevoflurane  104 69 85 85 102 
anju 25 female 65 161 sevoflurane  87 84 88 109 110 
kannagi 45 female 65 150 sevoflurane  103 90 76 79 80 
sathyapriya 22 female 40 147 sevoflurane  91 61 60 73 90 
kadhar basha 36 male 60 166 sevoflurane  101 88 97 86 84 
hema kumar 24 male 70 173 sevoflurane  76 66 66 66 76 
sabapathy 40 male 60 163 sevoflurane  80 76 81 76 71 
shankari 30 female 70 154 sevoflurane  90 76 78 81 80 
velu 48 male 65 161 sevoflurane  86 78 71 78 86 
anbu 42 male 65 168 sevoflurane  103 87 87 75 73 
parvathi 25 female 40 156 sevoflurane  79 64 64 74 95 
nandhini 19 female 50 156 sevoflurane  102 83 88 87 83 
ramya 15 female 50 158 sevoflurane  86 51 59 95 93 
balan 30 male 60 166 sevoflurane  85 69 60 69 71 
kuppan 60 male 60 162 sevoflurane  96 80 71 80 92 
vijayan 58 male 65 159 sevoflurane  106 81 124 82 82 
jerome 23 male 60 163 sevoflurane  80 79 94 94 96 
deepan 28 male 55 158 sevoflurane  81 65 80 79 96 
uma 30 female 60 159 sevoflurane  92 92 90 84 89 
ramani 28 female 70 151 sevoflurane  105 86 81 84 84 
dharmaraj 58 male 75 161 sevoflurane  97 86 89 74 85 
shanthi 42 female 60 155 sevoflurane  110 106 118 106 104 
kalaivani 25 female 50 158 sevoflurane  91 77 93 90 86 
ramzan 35 male 65 175 sevoflurane  101 81 75 75 77 
amarvalli 45 female 60 154 sevoflurane  121 69 65 73 73 
mymuna 35 female 55 150 sevoflurane  105 90 78 77 80 
sangeetha 30 female 50 157 sevoflurane  107 72 87 111 95 
hariprasath 16 male 50 161 sevoflurane  97 64 80 78 80 
gopi 27 male 60 166 sevoflurane  97 74 81 86 71 
karthik 17 male 50 151 sevoflurane  97 84 84 80 73 
thilagavathy 38 female 60 154 sevoflurane  97 59 83 81 76 
martha david 50 female 80 157 sevoflurane  103 94 94 91 91 
jaya 34 female 55 158 sevoflurane  101 84 59 77 79 
rajam 30 female 50 155 sevoflurane  97 84 75 77 80 
 
 
 
 
 
 
 
Intubating conditions, cough after intubation and cuff inflation, Cormack lehane grading, apnea: 
 
 
 
 
NAME AGE SEX WEIGHT HEIGHT GROUP 
INT CON 
COUG 
INT 
COUG 
INF C/L  APNEA  
murugan  40 male 60 158 propofol good moderate moderate 1 yes 
sathya 32 female 60 155 propofol optimal none none 2 yes 
vijayalakshmi 26 female 55 156 propofol good none mild 1 yes 
sriram 60 male 65 160 propofol marginal moderate moderate 3 yes 
krishnan 55 male 70 162 propofol good mild mild 3 yes 
poongodi 31 female 65 152 propofol optimal none none 1 yes 
mangai 48 female 60 155 propofol optimal none none 1 yes 
saranya 20 female 45 145 propofol good mild mild 1 yes 
anbalagan 16 male 50 150 propofol poor severe severe 1 yes 
sivagami 23 female 60 157 propofol good mild mild 1 yes 
manikandan 17 male 50 154 propofol good mild mild 1 yes 
nivedini 15 female 35 150 propofol optimal none none 1 yes 
palani 23 male 60 165 propofol marginal mild moderate 1 yes 
kalaivannan 28 male 67 162 propofol good mild mild 1 yes 
datchinamoorthy 52 male 58 166 propofol good mild moderate 1 yes 
chitra 45 female 70 157 propofol optimal none mild 1 yes 
ilayaraja 26 male 63 164 propofol marginal moderate moderate 2 yes 
manjula 32 female 63 158 propofol good none mild 2 yes 
prabu 19 male 55 154 propofol optimal none none 1 yes 
nagaraj 18 male 60 152 propofol marginal moderate moderate 2 yes 
rachel 29 female 50 157 propofol optimal none none 1 yes 
murugan  46 male 70 166 propofol optimal none none 1 yes 
shanthi 23 female 40 160 propofol optimal none none 1 yes 
anwar basha 35 male 70 168 propofol good none mild 2 yes 
loganayagi 31 female 60 155 propofol optimal none none 2 yes 
backiyam 40 female 55 157 propofol optimal none none 1 yes 
vishnupriya 15 female 35 145 propofol optimal none none 1 yes 
valliammal 50 female 55 151 propofol optimal none none 2 yes 
saraswathi 27 female 50 155 propofol optimal none none 1 yes 
andaal 35 female 70 153 propofol optimal none none 1 yes 
seenu kumar 30 male 45 158 propofol good mild mild 2 yes 
mala 32 female 70 161 propofol optimal none none 2 yes 
kala  36 female 50 155 propofol optimal none none 1 yes 
sridhar 42 male 60 170 propofol good none mild 1 yes 
lavanya 18 female 40 155 propofol marginal moderate moderate 1 yes 
suman 24 male 65 168 propofol optimal none none 1 yes 
palkish 44 female 60 153 propofol optimal none mild 2 yes 
mani  55 male 60 167 propofol marginal moderate moderate 2 yes 
meena 15 female 50 154 propofol optimal none none 1 yes 
selvadoss 35 male 54 162 propofol optimal none none 1 yes 
rosy 24 female 50 155 sevoflurane optimal none mild 1 no 
dhanam 33 female 60 158 sevoflurane good none mild 2 no 
desammal 40 female 40 162 sevoflurane optimal none none 1 no 
prema 45 female 55 155 sevoflurane optimal none mild 2 no 
poongodi 35 female 60 157 sevoflurane optimal none none 2 no 
kamalakannan 24 male 60 165 sevoflurane optimal none none 1 no 
subashini 25 female 50 155 sevoflurane optimal none none 1 yes 
anju 25 female 65 161 sevoflurane optimal none none 1 no 
kannagi 45 female 65 150 sevoflurane optimal none none 1 no 
sathyapriya 22 female 40 147 sevoflurane optimal none none 1 no 
kadhar basha 36 male 60 166 sevoflurane optimal none none 1 no 
hema kumar 24 male 70 173 sevoflurane optimal none none 2 no 
sabapathy 40 male 60 163 sevoflurane optimal none none 2 yes 
shankari 30 female 70 154 sevoflurane optimal none none 1 no 
velu 48 male 65 161 sevoflurane optimal none none 2 no 
anbu 42 male 65 168 sevoflurane optimal none none 1 no 
parvathi 25 female 40 156 sevoflurane optimal none none 1 no 
nandhini 19 female 50 156 sevoflurane good moderate moderate 1 no 
ramya 15 female 50 158 sevoflurane optimal none mild 1 no 
balan 30 male 60 166 sevoflurane optimal none none 2 no 
kuppan 60 male 60 162 sevoflurane optimal mild mild 2 no 
vijayan 58 male 65 159 sevoflurane good mild mild 2 yes 
jerome 23 male 60 163 sevoflurane optimal none none 1 no 
deepan 28 male 55 158 sevoflurane optimal none none 1 no 
uma 30 female 60 159 sevoflurane optimal none none 1 no 
ramani 28 female 70 151 sevoflurane optimal none none 1 no 
dharmaraj 58 male 75 161 sevoflurane optimal none none 1 no 
shanthi 42 female 60 155 sevoflurane optimal mild mild 1 yes 
kalaivani 25 female 50 158 sevoflurane optimal none none 1 no 
ramzan 35 male 65 175 sevoflurane optimal none none 1 no 
amarvalli 45 female 60 154 sevoflurane optimal none none 1 no 
mymuna 35 female 55 150 sevoflurane optimal none none 1 no 
sangeetha 30 female 50 157 sevoflurane optimal none none 1 no 
hariprasath 16 male 50 161 sevoflurane optimal none none 1 no 
gopi 27 male 60 166 sevoflurane optimal none none 1 no 
karthik 17 male 50 151 sevoflurane optimal none mild 1 yes 
thilagavathy 38 female 60 154 sevoflurane optimal none none 2 no 
martha david 50 female 80 157 sevoflurane optimal none mild 1 no 
jaya 34 female 55 158 sevoflurane optimal none none 1 no 
rajam 30 female 50 155 sevoflurane optimal none none 1 no 
 
